You are here

Inhibiting Prolyl Hydroxylase to Mimic Natural Acclimatization to High Altitude to Improve Warfighter Performance at High Altitude

Award Information
Agency: Department of Defense
Branch: Special Operations Command
Contract: H9222218P0037
Agency Tracking Number: S17C-001-0021
Amount: $148,496.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: SOCOM17C-001
Solicitation Number: 2017.0
Solicitation Year: 2017
Award Year: 2018
Award Start Date (Proposal Award Date): 2018-05-17
Award End Date (Contract End Date): 2018-11-19
Small Business Information
6382 South Geneva Cir
Englewood, CO 80111
United States
DUNS: 961856973
HUBZone Owned: No
Woman Owned: Yes
Socially and Economically Disadvantaged: No
Principal Investigator
 Robert Roach
 (303) 250-8195
Business Contact
 Barbara Lommen
Phone: (720) 284-7074
Research Institution
 University of Colorado AMC
 Pamela Alvarez
CU Denver Campus Box F-524 12469 E. 17th Place
Aurora, CO 80045
United States

 (303) 724-1671
 Nonprofit College or University

Acclimatization is the long-term adjustment that humans experience when exposed for weeks or months to high altitude. Acclimatization is important in this context because a warfighter who is acclimatized to high altitude is immune to high altitude illness, has superior work capacity, and has cognitive function approaching that found at sea level. In other words, the acclimatized warfighter is optimally equipped for task completion at high altitudes. Currently no drugs are known that will cause a warfighter to become acclimatized. We propose thatpre-treatment with proly hydroxylase inhibitors at low altitude will mimic acclimatization thus creating for warfighters during acute exposure to high altitude immunity to high-altitude illness, along with improved exercise and cognitive performance.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government